Kura Oncology (KURA) Shares Issued (2015 - 2026)
Kura Oncology (KURA) reported Shares Issued of $69000.0 for Q1 2026, down 51.75% year-over-year from $143000.0 in Q1 2025, and down 93.92% quarter-over-quarter from $1.1 million in Q4 2025.
Kura Oncology (KURA) Shares Issued (2015 - 2026) Analysis & Trends
Kura Oncology (KURA) has 11 years of Shares Issued data on file, last reported at $69000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $69000.0, down 51.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 72.24% YoY), and the FY2025 annual result was $1.8 million, down 79.16% from the prior year.
- Shares Issued declined to $69000.0 in Q1 2026 per KURA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Shares Issued peaked at $3.0 million in Q2 2024 and troughed at $69000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $749000.0 in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued jumped 2521.43% in 2024, then tumbled 94.4% in 2025.
- A 5-year view of Shares Issued shows it stood at $567000.0 in 2022, then rose by 21.87% to $691000.0 in 2023, then climbed by 16.79% to $807000.0 in 2024, then soared by 40.64% to $1.1 million in 2025, then slumped by 93.92% to $69000.0 in 2026.
- Business Quant data shows KURA's Shares Issued at $69000.0 in Q1 2026, $1.1 million in Q4 2025, and $515000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Jun 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 3.04 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 691,000.00 |
| Dec 31, 2023 | 691,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |